Prices delayed by at least 15 minutes | Print


STAAR Surgical Company (STAA)

Common Shares
Sell: $33|Buy: $48.64|Change: 0.93 (-1.94%)

Open 

$46.9


Previous close 

$47.82


Trade high 

$47.05


Volume 

350,028


Year high 

$73.13


Year low 

$26.66


Dividend yield 

-


Market capitalisation 

$2.29 bn


P/E ratio 

111.21


ISIN 

US8523123052


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 25/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
STAAR Surgical Company- 1.94
More...

Company profile

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses which are used in surgery that treat cataracts. The company offers two types of products which are Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.